Hairy cell leukaemia and occupational exposure to benzene

被引:11
|
作者
Clavel, J
Conso, F
Limasset, JC
Mandereau, L
Roche, P
Flandrin, G
Hemon, D
机构
[1] HOP COCHIN,SERV PATHOL PROFESSIONNELLE,F-75674 PARIS,FRANCE
[2] INST NATL RECH SECUR,NANCY,FRANCE
[3] HOP NECKER ENFANTS MALAD,CENT HEMATOL LAB,PARIS,FRANCE
关键词
case-control study; leukaemia hairy cell; benzene;
D O I
10.1136/oem.53.8.533
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives - The role of occupational exposures in hairy cell leukaemia (HCL) was investigated through a multicentre, hospital based, case-control study. This paper analyses the role of exposure to benzene in HCL. Methods - A population of 226 male cases of HCL and 425 matched controls were included in the study. Benzene exposure was evaluated by expert review of the detailed data on occupational exposures generated by case-control interviews. Results - No association was found between HCL and employment in a job exposed to benzene (odds ratio (OR) 0.9 (95% confidence interval (95% CI) 0.6-1.3)). The sample included 125 subjects, 34 cases (15%), and 91 controls (21%) who had been exposed to benzene, as individually assessed by the experts, for at least one hour a month during one of their jobs. Benzene exposure was not associated with a risk of HCL (OR 0.8 (0.5-1.2)). No trend towards an increase in OR was detected for increasing exposures, the percentage of work time involving exposure to > 1 ppm, or the duration of exposure. No findings suggested a particular risk period, when the OR associated with the time since first or last exposure, or since the end of exposure, were examined. Conclusions-in conclusion, with the low exposures prevalent in the sample, the study did not show any association between benzene exposure and HCL.
引用
收藏
页码:533 / 539
页数:7
相关论文
共 50 条
  • [41] VH gene expression in hairy cell leukaemia
    Maloum, K
    Magnac, C
    Azgui, Z
    Cau, C
    Charlotte, F
    Binet, JL
    Merle-Béral, H
    Dighiero, G
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (01) : 171 - 178
  • [42] The diagnosis and treatment of hairy-cell leukaemia
    Allsup, DJ
    Cawley, JC
    BLOOD REVIEWS, 2002, 16 (04) : 255 - 262
  • [43] Advances in the treatment of hairy-cell leukaemia
    Mey, U
    Strehl, J
    Gorschlüter, M
    Ziske, C
    Glasmacher, A
    Pralle, H
    Schmidt-Wolf, I
    LANCET ONCOLOGY, 2003, 4 (02): : 86 - 94
  • [44] Focal bone lesions in Hairy Cell Leukaemia
    Cross, M.
    Sharma, B.
    El-Sharkawi, D.
    Iyengar, S.
    Dearden, C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 : 170 - 171
  • [45] Skin lesions in a patient with hairy cell leukaemia
    Raanani, P
    Thaler, M
    Keller, N
    BenBassat, I
    POSTGRADUATE MEDICAL JOURNAL, 1997, 73 (860) : 375 - 377
  • [46] Hairy-cell leukaemia: Biology and management
    Pettitt, AR
    Zuzel, M
    Cawley, JC
    BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (01) : 2 - 8
  • [47] Reversible cardiomyopathy in a patient with hairy cell leukaemia
    Sucak, GT
    Haznedar, R
    Yalçin, R
    POSTGRADUATE MEDICAL JOURNAL, 1998, 74 (871) : 313 - 314
  • [48] Hairy cell leukaemia with unusual BRAF mutations
    Maitre, Elsa
    Macro, Margaret
    Troussard, Xavier
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2023, 27 (17) : 2626 - 2630
  • [49] Immunobiological treatments of hairy-cell leukaemia
    Kreitman, RJ
    Pastan, I
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2003, 16 (01) : 117 - 133
  • [50] Cladribine in the treatment of hairy-cell leukaemia
    Goodman, GR
    Beutler, E
    Saven, A
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2003, 16 (01) : 101 - 116